関連文献

The association between urinary liver-type fatty acid-binding protein and chronic kidney disease classification in HIV-infected Japanese patients.

Clin Exp Nephrol. 2016PubMed

Role of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate-salt hypertension.

FASEB J. 2016PubMed

Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case-control study.

Cardiovasc Diabetol. 15(1): 76, 2016.PubMed

Renoprotective effect of the xanthine oxidoreductase inhibitor, Topiroxostat,on Adenine-Induced Renal Injury.

Am J Physiol Renal Physiol. 310(11):F1366-1376, 2016.PubMed

Clinical utility of urinary liver-type fatty acid binding protein measured by latex-enhanced turbidimetric immunoassay in chronic kidney disease.

Clin Chem Lab Med. 2016.PubMed

Clinical significance of urinary liver-type fatty acid-binding protein as a predictor of ESRD and CVD in patients with CKD.

Clin Exp Nephrol. 20(2): 195-203, 2016.PubMed

Urinary markers in the early stage of nephropathy in patients with childhood-onset type 1 diabetes.

Pediatr Nephrol. 31(4):623-631, 2016.PubMed

Epoetin beta pegol alleviates oxidative stress and exacerbation of renal damage from iron deposition, thereby delaying CKD progression in progressive glomerulonephritis rats.

Physiol Rep. 3(12), 2015.PubMed

Urinary liver-type fatty acid-binding protein change in gestational diabetes mellitus.

Diabetes Res Clin Pract. 109(3): e36-e38, 2015.PubMed

Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study.

Clin J Am Soc Nephrol. 10(11):1956-1963, 2015.PubMed